MapLight Therapeutics

MPLTNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$703.441 M

$10.86 -0.37%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

-$161.2M

Loss-making

Shares outstanding

42,436,326

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#183Ironwood PharmaceuticalsIRWD$747.7M
#184Collegium PharmaceuticalCOLL$741.6M
#185MapLight TherapeuticsMPLT$703.4M
#186Zevra TherapeuticsZVRA$687.7M
#187Sagimet BiosciencesSGMT$683.0M

Insiders buying

All insider buying →

3 open-market purchases by officers and directors of MapLight Therapeutics, worth $65.5M. Grants and option exercises are excluded.

Catalyst4, Inc.$50.1M
4,400,000 shares at $11.38 on 14 Aug 2026 · filed 18 Aug 2026
Catalyst4, Inc.$15.3M
1,209,225 shares at $12.66 on 28 Jul 2026 · filed 30 Jul 2026
Troy Cox$148.7K
15,620 shares at $9.52 on 28 Jul 2026 · filed 28 Jul 2026

What if MapLight Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.2T

$466,763.73

Per share 42,980× higher

Bitcoin $1.74T

$26,888.34

Per share 2,476× higher

Nvidia $5.52T

$85,154.55

Per share 7,841× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for MapLight Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.